BBGBloomberg·2hBusiness
score-0.40
Novo Nordisk CEO Mike Doustdar States No Further Wegovy Discounts Are Being Discussed
Original
Novo Not Discussing Further Pill Discounts, CEO Says
“Framing emphasizes investor disappointment and refused discounts, signaling financial underperformance rather than direct harm.”